Vita 34
Vita 34 is Germany's first private cord blood bank, providing cryopreservation of umbilical cord blood and tissue stem cells for over 230,000 families across 20+ countries. Operating as a brand within FamiCord AG, it sells one-time processing plus recurring storage services via a GMP-certified Leipzig facility and a network covering 95%+ of German birth clinics.
- Company typePrivate
- Founded1997
- HeadquartersLeipzig, Germany
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Vita 34 does
Vita 34 is Germany's first private cord blood bank, founded in 1997 and headquartered in BioCity Leipzig, where it operates a GMP-certified laboratory and cryopreservation facility. The company provides private banking of umbilical cord blood (Nabelschnurblut), containing hematopoietic stem cells, and umbilical cord tissue (Nabelschnurgewebe), containing mesenchymal stem cells relevant to regenerative medicine. A distinguishing offering is the Familienoption (Family Option), under which stored cord blood is tested at no additional cost for suitability for family members beyond the donor child — a service Vita 34 states is unique in Germany. Samples are cryopreserved at approximately -180°C under pharmaceutical-grade quality controls, and the company has built research collaborations including with the University of Leipzig on mesenchymal stem cell applications.
Vita 34 generates revenue through a combination of one-time collection and processing fees and recurring long-term storage fees, with entry pricing around EUR 1,390 and multi-year contract structures. Its primary customer segment is expectant parents and families purchasing biological 'health insurance' against potential future disease, with documented storage outcomes across 80+ medical indications. Customer base exceeds 230,000 families across more than 20 countries, anchored in a domestic distribution network that partners with over 95% of German birth clinics for sample collection. Supporting channels include an online self-service configurator, toll-free inside sales, parent information evenings, webinars, baby fair participation, and a referral program.
Vita 34 was previously listed as Vita 34 AG and now operates as a subsidiary brand within FamiCord AG, which it identifies as Europe's largest private cord blood banking group. The corporate history includes multiple bolt-on acquisitions in the DACH region (Novel Pharma 2010, BioPlanta 2012, Stellacure 2014, Vivocell 2014, StemCare 2015, Seracell Pharma 2017), expanding both geographic reach and technical capabilities. Leadership is anchored by Prof. Emilian Snarski as Hematologist and Medical Director of FamiCord Group, supported by long-tenured scientific staff such as Dr. Marion Bartel leading specialist consulting. The company was recognized as 'Top StemCell Bank in Europe 2025'.
Vita 34 firmographics
Firmographics- Name
- Vita 34
- Legal name
- FamiCord AG
- Website
- https://vita34.de
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Vita 34 is Germany's first private cord blood bank, providing cryopreservation of umbilical cord blood and tissue stem cells for over 230,000 families across 20+ countries. Operating as a brand within FamiCord AG, it sells one-time processing plus recurring storage services via a GMP-certified Leipzig facility and a network covering 95%+ of German birth clinics.
- Ownership category
- akta.pro rank
Vita 34 industry classification
Industry- Product category
- Private Cord Blood Banking
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
Keywords
Where Vita 34 is headquartered
LocationHeadquarters
- HQ city
- Leipzig
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Vita 34 business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others
Revenue model
- Initial Collection and Processing Fee: One-time fee covering cord blood/tissue collection kit, medical questionnaire review, sample transport via specialized courier, laboratory processing and preparation for long-term storage.
- Long-term Storage Fee: Annual or multi-year fees for ongoing cryopreservation of stem cell samples at -180°C in secure storage tanks.
- Stem Cell Preparation Release: When stem cells are needed for medical treatment, Vita 34 handles the controlled release and transport of samples to treating medical facilities.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Starting package from 1,390 EUR |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels6 records
Vita 34 product offering
Product offeringCore offering
Vita 34 is Germany's first private stem cell bank, collecting, processing, and cryopreserving umbilical cord blood and cord tissue from newborns for long-term storage. The company offers the unique Familienoption (Family Option) service, which tests stored samples for compatibility with family members at no additional cost. Operations are performed in a GMP-certified laboratory in Leipzig, serving more than 230,000 customers across over 20 countries.
Product overview
Vita 34 is Germany's #1 German stem cell bank and the largest in Europe, offering private cord blood and cord tissue banking services for personal and family health preservation. The company provides two core storage products: Nabelschnurblut (cord blood banking) for hematopoietic stem cells used in treating blood cancers, immune disorders, and metabolic diseases; and Nabelschnurgewebe (cord tissue banking) for mesenchymal stem cells relevant to regenerative medicine. A differentiating add-on is the Familienoption (Family Option), which at no extra cost tests stored samples for suitability with family members. Stem cells are cryopreserved at approximately -180°C in GMP-certified facilities in Leipzig, Germany, with processing, storage, and release handled under strict quality standards. The company serves over 230,000 customers from more than 20 countries and works with over 95% of German birth clinics.
Differentiator
Problem solved
Functional benefit
Brands
- Familienoption: A unique service offering where stored cord blood is also tested for suitability for family members, not just the child.
- BioCity Leipzig
Products and services
- Cord Blood Banking
Quantifiable outcome
- Over 60,000 cord blood transplants performed worldwide for 80+ diseases
- +2 more outcomes
Companies that use Vita 34
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Vita 34 technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Vita 34 partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- EBMT (European Society for Blood and Marrow Transplantation)corePartnership with EBMT for stem cell transplantation research and clinical standards. Vita 34 collaborates on advancing stem cell banking practices and transplantation outcomes.
- WMDA (World Marrow Donor Association)coreMembership and collaboration with WMDA to maintain international standards for stem cell donor registries and cord blood banking globally.
- EAF-CBB (European Association of Families - Cord Blood Banking)corePartnership with European cord blood banking association to promote quality standards and family awareness about stem cell preservation.
- University of Leipzig - Hematology and Internal Oncology DepartmentcoreResearch collaboration on the effectiveness of mesenchymal stem cells from cord tissue in blood stem cell transplants. Joint project to suppress life-threatening immune reactions (GvHD). Funded by Sächsische Aufbaubank with 1.2 million euros. The project was nominated for the Health Media Award 2013.
- FamiCord AG (Parent Company)coreVita 34 is part of the FamiCord Group, Europe's largest private cord blood bank. Prof. Emilian Snarski serves as Hematologist and Medical Director of FamiCord Group.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Vita 34 competitors and assessment
Company assessmentDirect peers
- Cryo-Cell International: US-headquartered private cord blood and cord tissue bank with very similar product offering (collection kit processing + long-term cryopreservation) and direct-to-consumer subscription storage model; one of the closest global comparables to Vita 34.
- ViaCord: US cord blood and cord tissue bank offering private family banking with recurring storage fees and obstetrician/hospital collection partnerships — a direct functional peer for Vita 34.
- Cord Blood Registry (CBR): One of the largest US private cord blood banks, storing hematopoietic and mesenchymal stem cells for family use on a recurring-storage subscription model — directly comparable core offering.
- Cells4Life: UK-based private cord blood and cord tissue bank; offers whole-blood and cord tissue storage with multi-year storage contracts — a closely overlapping European peer.
- Smart Cells International: UK private stem cell bank focused on umbilical cord blood and tissue storage for family use with long-term subscription storage — closely comparable offering and B2C motion.
Broad incumbents
- Cryo-Save (Esperite Group): European-headquartered family stem cell banking group operating across multiple countries; broad incumbent with overlapping private cord blood and tissue banking services.
- FamiCord Group: Parent network of which Vita 34 is the German brand — Europe's largest private cord blood banking platform operating multiple national brands (Vivocell, Stellacure, etc.); directly comparable in scope and model.
Regional players
- StemCare: Scandinavian/Nordic private cord blood bank with overlapping core service (private collection + long-term storage); comparable regional peer acquired by Vita 34/FamiCord for consolidation context.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Vita 34 social profiles
Digital presenceVita 34 financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vita 34 leadership team
Management profileNumber of profiles
Profiles5 records
Vita 34 subsidiaries and ownership
Company hierarchySubsidiaries1 record
Vita 34 funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vita 34 M&A and investment
M&A and investmentM&A5 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vita 34
What does Vita 34 do?
Vita 34 is Germany's first private stem cell bank, collecting, processing, and cryopreserving umbilical cord blood and cord tissue from newborns for long-term storage. The company offers the unique Familienoption (Family Option) service, which tests stored samples for compatibility with family members at no additional cost. Operations are performed in a GMP-certified laboratory in Leipzig, serving more than 230,000 customers across over 20 countries.
Is Vita 34 a public or private company?
Vita 34 is a private company. It is classified as corporate owned and is currently operating.
When was Vita 34 founded?
Vita 34 was founded in 1997. It employs 51 to 100 people.
Where is Vita 34 based?
Vita 34 is headquartered in Leipzig, Germany, in the Europe region.
How does Vita 34 make money?
Three revenue lines are on record. Initial Collection and Processing Fee is the primary driver. The others are long-term Storage Fee and stem Cell Preparation Release.
Who are Vita 34's main competitors?
Direct peers on record are Cryo-Cell International, ViaCord, Cord Blood Registry (CBR), Cells4Life and Smart Cells International. Broad incumbents are Cryo-Save (Esperite Group) and FamiCord Group. StemCare is listed as a regional player.
Does Vita 34 have an API?
No public API is recorded for Vita 34.
What industry is Vita 34 in?
Vita 34's product category is Private Cord Blood Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 2836.